The Interventricular Septal Hematoma Following Surgical Correction of Ventricular Septal Defect in Infants: A Single-Center Experience

Authors

  • Ling-Shan Yu, MM Department of Cardiac Surgery, Fujian Branch of Shanghai Children’s Medical Center, Fuzhou, China
  • Wen-Hao Lin, MM Department of Cardiac Surgery, Fujian Branch of Shanghai Children’s Medical Center, Fuzhou, China
  • Shi-Hao Lin, MM Department of Cardiac Surgery, Fujian Branch of Shanghai Children’s Medical Center, Fuzhou, China
  • Jing Wang, MD Department of Cardiac Surgery, Fujian Branch of Shanghai Children’s Medical Center, Fuzhou, China
  • Hua Cao, MD Department of Cardiac Surgery, Fujian Branch of Shanghai Children’s Medical Center, Fuzhou, China
  • Zeng-Chun Wang, MD Department of Cardiac Surgery, Fujian Branch of Shanghai Children’s Medical Center, Fuzhou, China
  • Qiang Chen, MD Department of Cardiac Surgery, Fujian Branch of Shanghai Children’s Medical Center, Fuzhou, China

DOI:

https://doi.org/10.1532/hsf.4657

Keywords:

infants, ventricular septal defect, interventricular septal hematoma

Abstract

Objective: To review and analyze the cases of interventricular septal hematoma (IVSH) following surgical correction of the ventricular septal defect (VSD) in infants in our center.

Methods: Retrospective analysis was performed on five infants with IVSH after surgical correction of VSD in our center from January 2020 to January 2022. The general preoperative information and intraoperative and postoperative results were collected and analyzed.

Results: All five infants with VSD were repaired under cardiopulmonary bypass and occurred IVSH. The cardiac arrest occurred in one patient five hours after return to the intensive care unit (ICU). The patient’s hemodynamics were difficult to maintain after cardiopulmonary resuscitation, and the patient died. Two other patients had arrhythmia and unstable hemodynamics during the perioperative period, the hematoma puncture was performed, and the patients’ symptoms lessened. Perioperative and postoperative echocardiography showed that the hematoma gradually was shrunk, and the hemodynamics became stable. The hemodynamics were stable in the remaining two infants during the perioperative period. No specific medical intervention was required other than clinical observation in these two patients. Finally, the four infants successfully were discharged with good clinical results.

Conclusion: IVSH is a rare complication of surgical repair of VSD. Prevention and early detection of IVSH during operation in infants with VSD are essential. 

References

Bailey FJ, Jivanji SG, Kostolny M. 2017. Postoperative interventricular septal haematoma following tetralogy of Fallot repair and perimembranous ventricular septal defect repair. Interact Cardiovasc Thorac Surg. Feb 1;24(2):296-298.

Bettex DA, Prêtre R, Jenni R, Schmid ER. 2005. Cost-effectiveness of routine intraoperative transesophageal echocardiography in pediatric cardiac surgery: a 10-year experience. Anesth Analg. May;100(5):1271-1275.

Burkhart HM, Thompson JL, Buckley KW. 2020. Commentary: Postoperative interventricular septal hematoma-Never say never. J Thorac Cardiovasc Surg. May;159(5):1943-1944.

Chen Q, Hong ZN, Zhang GC, Chen LW, Zhang QL, Lin ZW, Cao H. 2018. Intraoperative Device Closure of Isolated Ventricular Septal Defects: Experience on 1,090 Cases. Ann Thorac Surg. Jun;105(6):1797-1802.

Drago M, Butera G, Giamberti A, Lucente M, Frigiola A. 2005. Interventricular septal hematoma in ventricular septal defect patch closure. Ann Thorac Surg. May;79(5):1764-5.

Eyileten Z, Aliyev A, Çiftçi Ö, Uçar T, Ödek Ç, Kendirli T, Tutar E, Atalay S, Uysalel A. 2013. An extremely rare complication of congenital heart surgery: interventricular septal hematoma. Turk J Pediatr. Nov-Dec;55(6):662-4.

Haranal M, Hew CC, Dillon JJ. 2019. Myocardial Rupture Secondary to Ventricular Septal Hematoma: A Case Report and Review of Contemporary Literature. World J Pediatr Congenit Heart Surg. Nov;10(6):793-795.

Jegatheeswaran A, Cohen MS, Gaynor JW, Mascio CE, Spray TL, Fuller S. 2020. Extracorporeal membrane oxygenation as a novel management strategy for interventricular septal hematoma following ventricular septal defect repair. J Thorac Cardiovasc Surg. May;159(5):1936-1940.

Jensen R, Burg P, Anderson C, Garabedian C, Garabedian H, Siwek L, Worrall N. 2007. Postoperative ventricular septal hematoma: natural history of two pediatric cases. J Thorac Cardiovasc Surg. Jun;133(6):1651-2.

Mart CR, Kaza AK. 2011. Postoperative dissecting ventricular septal hematoma: recognition and treatment. ISRN Pediatr. 2011:534940.

Padalino MA, Speggiorin S, Pittarello D, Milanesi O, Stellin G. 2007. Unexpected interventricular septal hematoma after ventricular septal defect closure: intraoperative echocardiographic early detection. Eur J Echocardiogr. Oct;8(5):395-7.

Suteu CC, Muntean I, Benedek T, Togănel R. 2016. Giant dissecting ventricular septal haematoma associated with critical congenital heart disease. Interact Cardiovasc Thorac Surg. Nov;23(5):837-838.

Vargas-Barrón J, Roldán FJ, Romero-Cárdenas A, Molina-Carrión M, Vázquez-Antona CA, Zabalgoitia M, Martínez Rios MA, Pérez JE. 2009. Dissecting intramyocardial hematoma: clinical presentation, pathophysiology, outcomes and delineation by echocardiography. Echocardiography. Mar;26(3):254-61.

Zhu J, Liu H, Zhang J, Feng X, Wu S, Mei J, Ding F. 2013. Interventricular septal hematoma after congenital cardiac surgery. Ann Thorac Surg. Jun;95(6):2171-3.

Published

2022-06-23

How to Cite

Ling-Shan Yu, Lin, W.-H. ., Lin, S.-H., Jing Wang, Cao, H., Zeng-Chun Wang, & chen, qiang. (2022). The Interventricular Septal Hematoma Following Surgical Correction of Ventricular Septal Defect in Infants: A Single-Center Experience. The Heart Surgery Forum, 25(3), E469-E472. https://doi.org/10.1532/hsf.4657

Issue

Vol. 25 No. 3 (2022)

Section

Articles

Author Disclosure & Copyright Transfer Agreement

In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.

A current form follows:

The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.

However, Publisher grants back to the author(s) the following:

  1. The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
  2. The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
  3. The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
  4. The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
  5. The right to make oral presentations of material from this work.

Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.

I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.

I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).

I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.

Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).